In Silico Approach for Predicting Toxicity of Peptides and Proteins S Gupta, P Kapoor, K Chaudhary, A Gautam, R Kumar, ... PloS one 8 (9), e73957, 2013 | 1364 | 2013 |
In Silico Models for Designing and Discovering Novel Anticancer Peptides A Tyagi, P Kapoor, R Kumar, K Chaudhary, A Gautam, GPS Raghava Scientific reports 3 (1), 2984, 2013 | 282 | 2013 |
In silico approaches for designing highly effective cell penetrating peptides A Gautam, K Chaudhary, R Kumar, A Sharma, P Kapoor, A Tyagi, ... Journal of translational medicine 11, 1-12, 2013 | 280 | 2013 |
CPPsite: a curated database of cell penetrating peptides A Gautam, H Singh, A Tyagi, K Chaudhary, R Kumar, P Kapoor, ... Database 2012, bas015, 2012 | 241 | 2012 |
Single-cell analysis of germinal-center B cells informs on lymphoma cell of origin and outcome AB Holmes, C Corinaldesi, Q Shen, R Kumar, N Compagno, Z Wang, ... Journal of Experimental Medicine 217 (10), e20200483, 2020 | 154 | 2020 |
Peptide toxicity prediction S Gupta, P Kapoor, K Chaudhary, A Gautam, R Kumar, GPS Raghava Computational Peptidology, 143-157, 2015 | 147 | 2015 |
TumorHoPe: a database of tumor homing peptides P Kapoor, H Singh, A Gautam, K Chaudhary, R Kumar, GPS Raghava PLoS One 7 (4), e35187, 2012 | 146 | 2012 |
An in silico platform for predicting, screening and designing of antihypertensive peptides R Kumar, K Chaudhary, J Singh Chauhan, G Nagpal, R Kumar, ... Scientific reports 5 (1), 12512, 2015 | 137 | 2015 |
CancerDR: cancer drug resistance database R Kumar, K Chaudhary, S Gupta, H Singh, S Kumar, A Gautam, P Kapoor, ... Scientific reports 3 (1), 1445, 2013 | 133 | 2013 |
Recurrent hotspot mutations in HRAS Q61 and PI3K-AKT pathway genes as drivers of breast adenomyoepitheliomas FC Geyer, A Li, AD Papanastasiou, A Smith, P Selenica, KA Burke, ... Nature communications 9 (1), 1816, 2018 | 132 | 2018 |
Precision radiotherapy: reduction in radiation for oropharyngeal cancer in the 30 ROC trial N Riaz, E Sherman, X Pei, H Schöder, M Grkovski, R Paudyal, N Katabi, ... JNCI: Journal of the National Cancer Institute 113 (6), 742-751, 2021 | 124 | 2021 |
Loss-of-function mutations in ATP6AP1 and ATP6AP2 in granular cell tumors F Pareja, AH Brandes, T Basili, P Selenica, FC Geyer, D Fan, ... Nature Communications 9 (1), 3533, 2018 | 109 | 2018 |
E-Cadherin/ROS1 Inhibitor Synthetic Lethality in Breast Cancer I Bajrami, R Marlow, M van de Ven, R Brough, HN Pemberton, J Frankum, ... Cancer Discovery 8 (4), 498-515, 2018 | 105 | 2018 |
The landscape of somatic genetic alterations in breast cancers from ATM germline mutation carriers B Weigelt*, R Bi*, R Kumar*, P Blecua, DL Mandelker, FC Geyer, F Pareja, ... JNCI: Journal of the National Cancer Institute 110 (9), 1030-1034, 2018 | 105 | 2018 |
Elevated APOBEC3B expression drives a kataegic-like mutation signature and replication stress-related therapeutic vulnerabilities in p53-defective cells J Nikkilä, R Kumar, J Campbell, I Brandsma, HN Pemberton, F Wallberg, ... British journal of cancer 117 (1), 113-123, 2017 | 104 | 2017 |
Tumor homing peptides as molecular probes for cancer therapeutics, diagnostics and theranostics A Gautam, P Kapoor, K Chaudhary, R Kumar, GPS Raghava, ... Current medicinal chemistry 21 (21), 2367-2391, 2014 | 95 | 2014 |
MYBL1 rearrangements and MYB amplification in breast adenoid cystic carcinomas lacking the MYB‐NFIB fusion gene J Kim, FC Geyer, LG Martelotto, CKY Ng, RS Lim, P Selenica, A Li, ... The Journal of pathology, 2017 | 86 | 2017 |
Computational approach for designing tumor homing peptides A Sharma, P Kapoor, A Gautam, K Chaudhary, R Kumar, JS Chauhan, ... Scientific reports 3 (1), 1607, 2013 | 85 | 2013 |
Analysis of mutational signatures in primary and metastatic endometrial cancer reveals distinct patterns of DNA repair defects and shifts during tumor progression CW Ashley, ADC Paula, R Kumar, D Mandelker, X Pei, N Riaz, ... Gynecologic oncology 152 (1), 11-19, 2019 | 82 | 2019 |
The genomic landscape of mucinous breast cancer F Pareja, JY Lee, DN Brown, S Piscuoglio, R Gularte-Mérida, P Selenica, ... JNCI: Journal of the National Cancer Institute 111 (7), 737-741, 2019 | 80 | 2019 |